Endothelial progenitor cells possess monocyte-like antigen-presenting and t-cell-co-stimulatory capacity

Transplantation

Volumn 87, Issue 3, 2009, Pages 340-349

  Raemer, Patrick C ^a   Haemmerling, Susanne ^a,c   Giese, Thomas ^a   Canaday, David H ^b   Katus, Hugo A ^a   Dengler, Thomas J ^a   Shankar, Sivanandam G Vijay ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Antigen presentation; Co stimulation; EPC; T cells; Transplantation

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD28 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL ANTIGEN; FIBRONECTIN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; T LYMPHOCYTE RECEPTOR; THYMIDINE; ANTIGEN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; CULTURE TECHNIQUE; HYBRIDOMA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; UMBILICAL VEIN;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-PRESENTING CELLS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; LYMPHOCYTE ACTIVATION; MICE; MONOCYTES; STEM CELLS; T-LYMPHOCYTES; UMBILICAL VEINS;

EID: 61849163362     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181957308     Document Type: Article

References (31)

1. Zhao DX, Hu Y, Miller GG, et al. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 2002; 169: 1556.
2. Libby P, Zhao DX. Allograft arteriosclerosis and immune-driven an-giogenesis. Circulation 2003; 107: 1237.
3. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422.
4. Dzau VJ, Gnecchi M, Pachori AS, et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005; 46: 7.
5. Choi J, Enis DR, Koh KP, et al. T lymphocyte-endothelial cell interactions. Annu Rev Immunol 2004; 22: 683.
6. Urbich C, Heeschen C, Aicher A, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108: 2511.
7. Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164.
8. Gleissner CA, Zastrow A, Klingenberg R, et al. IL-10 inhibits endothelium-dependent T cell costimulation by up-regulation of ILT3/4 in human vascular endothelial cells. Eur J Immunol 2007; 37: 177.
9. Subklewe M, Chahroudi A, Schmaljohn A, et al. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. Blood 1999; 94: 1372.
10. Banerjee DK, Dhodapkar MV, Matayeva E, et al. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 2006; 108: 2655.
11. Canaday DH, Gehring A, Leonard EG, et al. T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing. J Immunol Methods 2003; 281: 129.
12. Canaday DH, Chakravarti S, Srivastava T, et al. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cell Immunol 2006; 243: 96.
13. Suzuki T, Hashimoto S, Toyoda N, et al. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000; 96: 2584.
14. Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86: 1408.
15. Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000; 164: 5146.
16. Ma W, Pober JS. Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998; 161: 2158.
17. Congia M, Patel S, Cope AP, et al. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA 1998; 95: 3833.
18. Khayyamian S, Hutloff A, Buchner K, et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci USA 2002; 99: 6198.
19. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005; 39: 733.
20. Seino K, Azuma M, Bashuda H, et al. CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. Int Immunol 1995; 7:1331.
21. Tan PH, Chan C, Xue SA, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis 2004; 173: 171.
22. McDouall RM, Page CS, Hafizi S, et al. Alloproliferation of purified CD4+ T cells to adult human heart endothelial cells, and study of second-signal requirements. Immunology 1996; 89: 220.
23. Denton MD, Geehan CS, Alexander SI, et al. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation. J Exp Med 1999; 190:555.
24. Fernandez Pujol B, Lucibello FC, Gehling UM, et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000; 65: 287.
25. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100: 2426.
26. Murray AG, Libby P, Pober JS. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol 1995; 154: 151.
27. Rose ML. Endothelial cells as antigen-presenting cells: Role in human transplant rejection. Cell Mol Life Sci 1998; 54: 965.
28. Karmann K, Pober JS, Hughes CC. Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. J Immunol 1994; 153: 3929.
29. Le Blanc K, Rasmusson I, Gotherstrom C, et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004; 60: 307.
30. Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821.
31. Marelli-Berg FM, Hargreaves RE, CarmichaelP, et al. Major histocompatibility complex class II-expressing endothelial cells induce allospe-cific nonresponsiveness in naive T cells. J Exp Med 1996; 183: 1603.